Cited by 33Thyroid Disorders and TreatmentsCardiovascular Function and Risk FactorsThyroid and Parathyroid Surgery

Subclinical hyperthyroidism is not associated with progression of cardiac mass and development of left ventricular hypertrophy in middle‐aged and older subjects: results from a 5‐year follow‐up

Dörr, Marcus, Ittermann, Till, Aumann, Nicole, Obst, Anne, Reffelmann, Thorsten, Nauck, Matthias, Wallaschofski, Henri, Felix, Stephan B. +1 more·2010·Clinical Endocrinology

Abstract

Summary: Background Decreased serum TSH levels are associated with increased cardiovascular mortality in elderly, and subclinical hyperthyroidism (SCH) was associated with left ventricular hypertrophy (LVH) as a predictor of cardiovascular mortality in some cross‐sectional and case‐control studies. The aim was to assess whether SCH independently impacts development of LVH over time. Methods Of 3300 participants of the population‐based Study of Health in Pomerania those with overt hyperthyroidism, hypothyroidism, possible thyroid disease or missing echocardiographic baseline data or follow‐up were excluded, resulting in a study population of 1112 individuals (556 women) aged 45–81 years. Echocardiographic left ventricular mass divided by height 2·7 (LVMI ht), and LVH ht (LVMI ht >44 g/m 2·7 in women and >48 g/m 2·7 in men) was measured at baseline and after 5‐year follow‐up (median 5·00; range 4·92; 5·08). Comparison of subjects with (n = 107) and without (n = 1005) SCH were made by linear and logistic regression models adjusted for age, gender, smoking status, hypertension, and waist circumference. Results At follow‐up, LVMI ht did not differ between subjects with and without SCH (50·2 g/m 2·7, interquartile range (IQR) 41·2; 59·5 vs 47·8 g/m 2·7, IQR 39·3; 56·9; P = 0·29). LVH ht was present in 66 (61·7%) subjects with and 543 (54·0%) persons without SCH (P = 0·13). Analyses revealed no association between SCH and progression of LVMI ht (β = −0·18; 95%‐confidence interval (CI) −2·34; −1·99; P = 0·873), and development of LVH ht (relative risk 0·86, 95%‐CI 0·60; 1·26; P = 0·462), respectively. Conclusions In this population‐based sample, SCH had no impact on progression of LVMI and development of LVH during 5‐year follow‐up in subjects aged 45 years or older.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2010.03882.x

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Two recent prospective studies did not find a link between subclinical hyperthyroidism and left ventricular mass in elderly subjects.

    “On the other hand, two recent prospective studies did not find a link between SHyper and left ventricular mass in elderly subjects [69,70] , almost certainly because SHyper has not been associated with symptoms of adrenergic overactivity in the elderly [50] .”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dörr, M., Ittermann, T., Aumann, N., Obst, A., Reffelmann, T., Nauck, M., Wallaschofski, H., Felix, S. B., & Völzke, H.
Affiliations
Universität Greifswald (DE)
Corresponding author
Dörr, Marcus
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2010-11-16
Volume
73
Issue
6
Pages
821-826
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2114768062
Cited by
33
References
41
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 1 · 2013: 3 · 2012: 3
FWCI
3.14
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
Keywords
subclinical hyperthyroidism, left ventricular hypertrophy, left ventricular mass index, cardiovascular risk, thyroid function, thyroid-stimulating hormone, middle-aged and older adults, Study of Health in Pomerania, echocardiography, cardiovascular mortality, hypertension, obesity, smoking, waist circumference, sex differences, longitudinal follow-up, cardiovascular risk factors, cardiovascular risk stratification
MeSH terms
Adult, Aged, Aged, 80 and over, Echocardiography, Female, Humans, Hyperthyroidism, Male, Middle Aged, Linear Models, Logistic Models, Hypertrophy, Left Ventricular, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review